TITLE

Increased frequency of hemodialysis reduced adverse clinical outcomes

AUTHOR(S)
Nesrallah, Gihad E.
PUB. DATE
April 2011
SOURCE
ACP Journal Club;4/17/2011, Vol. 154 Issue 4, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study which observed whether increasing the frequency of treatment can reduce adverse clinical outcomes in patients undergoing maintenance hemodialysis (HD). The study was conducted by researcher G.M. Chertow and his colleagues, and was published in a 2010 issue of the "New England Journal of Medicine." The study concluded that increasing the frequency of treatment reduced some adverse clinical outcomes in patients undergoing maintenance dialysis.
ACCESSION #
64279636

 

Related Articles

  • 2010 - Increased frequency of hemodialysis reduced adverse clinical outcomes. Nesrallah, Gihad E. // ACP Journal Club;4/17/2011, Vol. 154 Issue 4, p5 

    Question Does increasing the frequency of treatment reduce adverse clinical outcomes in patients undergoing maintenance hemodialysis (HD)? Methods Design Randomized controlled trial (Frequent Hemodialysis Network [FHN] Trial). ClinicalTrials.gov NCT00264758. Allocation {Concealed}*.†...

  • Physical Function and Gait Speed In Patients with Chronic Kidney Disease. Painter, Patricia; Marcus, Robin // Nephrology Nursing Journal;Nov/Dec2013, Vol. 40 Issue 6, p529 

    Patients with chronic kidney disease (CKD) who are treated with dialysis have impaired physical functioning that is associated with poor outcomes. Gait speed is an important measure of mobility that predicts adverse events and mortality in older people. Gait speed is low in patients with CKD,...

  • A multidisciplinary approach to hemodialysis access: Prospective evaluation. Allon, Michael; Bailey, Robert // Kidney International;Feb1998, Vol. 53 Issue 2, p473 

    Examines a multidisciplinary method to hemodialysis access. Aims to improve outcomes and reduce the cost of hemodialysis access procedures; Increase in the rate of graft declots; Decrease in the surgical complications of graft surgery.

  • In-Center Hemodialysis Six Times per Week versus Three Times per Week.  // New England Journal of Medicine;12/9/2010, Vol. 363 Issue 24, p2287 

    Background: In this randomized clinical trial, we aimed to determine whether increasing the frequency of in-center hemodialysis would result in beneficial changes in left ventricular mass, self-reported physical health, and other intermediate outcomes among patients undergoing maintenance...

  • Vascular Access Team Collaboration To Decrease Catheter Rates in Patients On Hemodialysis: Utilization of Kotter's Change Process. Mbamalu, Genevieve; Whiteman, Kimberly // Nephrology Nursing Journal;May/Jun2014, Vol. 41 Issue 3, p283 

    Long-term central venous catheter (CVC) use among patients on hemodialysis increases the risk of infection, morbidity, and mortality. This article describes the use of Kotter's process of change to establish a multidisciplinary vascular access team to facilitate the replacement of CVCs with...

  • Clinical and biochemical correlates of starting “daily” hemodialysis. Woods, John D.; Port, Friedrich K.; Orzol, Sean; Buoncristiani, Umberto; Young, Eric; Wolfe, Robert A.; Held, Philip J. // Kidney International;Jun1999, Vol. 55 Issue 6, p2467 

    Clinical and biochemical correlates of starting “daily” hemodialysis. Background. Daily hemodialysis has been proposed to improve outcomes for patients with end-stage renal disease. There has been increasing evidence that daily hemodialysis might have potential advantages over...

  • Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations. Van Buren, Peter; Inrig, Jula // Pediatric Nephrology;Mar2012, Vol. 27 Issue 3, p339 

    Hypertension is prevalent in adult and pediatric end-stage renal disease patients on hemodialysis. Volume overload is a primary factor contributing to hypertension, and attaining true dry weight remains a priority for nephrologists. Other contributing factors to hypertension include activation...

  • Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis. Dember, Laura M.; Beck, Gerald J.; Allon, Michael; Delmez, James A.; Dixon, Bradley S.; Greenberg, Arthur; Himmelfarb, Jonathan; Vazquez, Miguel A.; Gassman, Jennifer J.; Greene, Tom; Radeva, Milena K.; Braden, Gregory L.; Ikizler, T. Alp; Rocco, Michael V.; Davidson, Ingemar J.; Kaufman, James S.; Meyers, Catherine M.; Kusek, John W.; Feldman, Harold I. // JAMA: Journal of the American Medical Association;5/14/2008, Vol. 299 Issue 18, p2164 

    The article presents a study seeking to determine whether the drug clopidogrel reduces early failure of hemodialysis fistulas among patients treated with hemodialysis. The design, setting, and participants of the double-blind, placebo controlled trial involving 877 patients with end-stage renal...

  • Reply from the Authors. Kalantar-Zadeh, Kamyar; Block, Gladys; Humphreys, Michael H.; Kopple, Joel D. // Kidney International;Sep2003, Vol. 64 Issue 3, p1138 

    The author reiterated that the relationship between an increased weight and a better clinical outcome in dialysis patients is not completely uniform. For example, as we mentioned in our review, in Asian American hemodialysis patients, a conventional pattern has been shown. However, the general...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics